Bumetanide Tablet
Product Images NDC 0904-7016

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0904-7016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Bumetanide Tablets 1)

Chemical structure of bumetanide, showing its molecular arrangement with functional groups attached to a benzene ring, including carboxyl, sulfonamide, amine, and phenoxy groups.*

FDA Label Image

D0a07b46 30f7 4e35 9995 B060d8c397c9 00

Bumetanide Tablets, USP 1 mg oral tablets by Major Pharmaceuticals. The label shows this is a prescription-only unit dose package containing 30 tablets. It includes dosage information and storage instructions, noting the product is for institutional use only. Labeler and distributor addresses are provided, along with the NDC 0904-7016-04 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.